NCT03383055
- Conditions
- Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +14 more
- Locations
-
- Masonic Cancer Center at University of Minnesota Minneapolis, Minnesota, United States
Clinical trial condition
Lymphoma
Explore clinical trials studying Lymphoma. Study availability and eligibility vary by location and protocol.
2,141 public trials
305 recruiting studies
Lymphoma trial results
NCT00285428
- Conditions
- Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +7 more
- Locations
-
- New York Presbyterian Hospital/Cornell Medical Center New York, United States
- University Hospital of Pennsylvania Philadelphia, Pennsylvania, United States
- MD Anderson Cancer Center Houston, Texas, United States
Completed
Polatuzumab Vedotin in Patients With Relapsed and Refractory Diffuse Large B Cell Lymphoma
NCT05006534
- Conditions
- Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +10 more
- Locations
-
- National Taiwan University Hospital Taipei, Taiwan
NCT00003816
- Conditions
- Anemia, Anemia, Aplastic, Anemia, Refractory, +90 more
- Locations
-
- Roswell Park Cancer Institute Buffalo, New York, United States
Completed
Glutamic Acid in Reducing Nerve Damage Caused by Vincristine in Young Patients With Cancer
NCT00369564
- Conditions
- Burkitt Lymphoma, Chemically-Induced Disorders, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, +46 more
- Locations
-
- Lee Cancer Care of Lee Memorial Health System Fort Myers, Florida, United States
- Butterworth Hospital at Spectrum Health Grand Rapids, Michigan, United States
- Children's Hospitals and Clinics of Minnesota - Minneapolis Minneapolis, Minnesota, United States
- Hackensack University Medical Center Cancer Center Hackensack, New Jersey, United States
NCT02992483
- Conditions
- Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +15 more
- Locations
-
- MD Anderson Cancer Center/University of Texas MD Anderson CC Houston, Texas, United States
- Novartis Investigative Site Heidelberg, Victoria, Australia
- Novartis Investigative Site Nantes, France
- Novartis Investigative Site Heidelberg, Germany
NCT01122472
- Conditions
- Diffuse Large B-cell Lymphoma, Hemic and Lymphatic Diseases, Immune System Diseases, +9 more
- Locations
-
- Bendigo Hospital Bendigo, Australia
- Concord Repatriation General Hospital Concord, Australia
- Flinders Medical Centre - Repatriation General Hospital Daw Park, Australia
- St Vincent's Hospital, Melbourne Fitzroy, Australia
NCT02925000
- Conditions
- Cancer, Hemic and Lymphatic Diseases, Immune System Diseases, +6 more
- Locations
-
- Karmanos Cancer Center Detroit, Michigan, United States
- Montefiore Medical Center The Bronx, New York, United States
- Taipei Veterans General Hospital Taipei, Taiwan
NCT00726700
- Conditions
- Burkitt Lymphoma, DNA Virus Infections, Epstein-Barr Virus Infections, +25 more
- Locations
-
Not specified
NCT04439240
- Conditions
- Advanced Lymphoma, Advanced Malignant Solid Neoplasm, Blood Protein Disorders, +22 more
- Locations
-
- ECOG-ACRIN Cancer Research Group Philadelphia, Pennsylvania, United States